Literature DB >> 31473867

Low-level laser therapy for weight reduction: a randomized pilot study.

Ivana T Croghan1,2, Ryan T Hurt3, Darrell R Schroeder4, Shawn C Fokken5, Michael D Jensen6, Matthew M Clark7, Jon O Ebbert8.   

Abstract

Obesity and overweight is a global health crisis and novel methods of treatment are needed to address it. Low-level laser therapy (LLLT) is a currently available non-invasive procedure for lysing excess fat, but there is a lack of consensus exists on LLLT frequency and limited research from studies of LLLT. The purpose of this pilot study is to compare the effect of three of the most common LLLT frequencies on weight, waist circumference, body fat percentage, and quality of life. Sixty overweight (body mass index (BMI) 25-29.9 kg/m2) adult participants were randomized to 12 LLLT treatments: (1) three times weekly for 4 weeks, (2) twice weekly for 6 weeks, or (3) once weekly for 12 weeks. All participants attended an in-person visit at baseline and at weeks 4, 6, 12, and 26. Participants were recruited September 30, 2016 through to August 27, 2017. The majority of the 60 participants were female (90%) with an average age of 43.7 years (± 9.2 years). Most participants (98%) completed 10 or more of the 12 LLLT treatments. When comparing across treatment groups, the greatest reductions from baseline were observed in those assigned to twice weekly for 6 weeks in weight (1 ± 1.7 (±SD) kg by week 6), waist circumference (- 2.0 ± 3.2 in. by week 6 and - 1.5 ± 3.2 in. by week 26), body mass index (- 0.4 ± 0.6 kg/m2), and body fat mass (- 1.1 ± 1.6 kg). This group also had the most significant improvement from baseline in quality of life (+ 0.5 ± 0.8 by week 6), body satisfaction (+ 0.2 ± 0.4 by week 6 and week 26), and body appreciation (+ 0.2 ± 0.3 by week 6 and + 0.3 ± 0.3 by week 26). LLLT twice weekly for 6 weeks could be proposed as the optimal frequency and duration for the management of body weight. Trial registration: https://clinicaltrials.gov/ct2/show/NCT02877004. Registered August 24, 2016.

Entities:  

Keywords:  Adiposity; Clinical trial; Overweight; Weight loss

Mesh:

Year:  2019        PMID: 31473867     DOI: 10.1007/s10103-019-02867-5

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  37 in total

Review 1.  Evaluating preference effects in partially unblinded, randomized clinical trials.

Authors:  Scott D Halpern
Journal:  J Clin Epidemiol       Date:  2003-02       Impact factor: 6.437

2.  Design issues of randomized phase II trials and a proposal for phase II screening trials.

Authors:  Lawrence V Rubinstein; Edward L Korn; Boris Freidlin; Sally Hunsberger; S Percy Ivy; Malcolm A Smith
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  The impact of weight loss on health-related quality-of-life: implications for cost-effectiveness analyses.

Authors:  Amy E Rothberg; Laura N McEwen; Andrew T Kraftson; Gina M Neshewat; Christine E Fowler; Charles F Burant; William H Herman
Journal:  Qual Life Res       Date:  2013-10-16       Impact factor: 4.147

Review 5.  Noninvasive body contouring with radiofrequency, ultrasound, cryolipolysis, and low-level laser therapy.

Authors:  R Stephen Mulholland; Malcolm D Paul; Charbel Chalfoun
Journal:  Clin Plast Surg       Date:  2011-07       Impact factor: 2.017

6.  Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study.

Authors:  Patrick M O'Neil; Steven R Smith; Neil J Weissman; Meredith C Fidler; Matilde Sanchez; Jinkun Zhang; Brian Raether; Christen M Anderson; William R Shanahan
Journal:  Obesity (Silver Spring)       Date:  2012-03-16       Impact factor: 5.002

7.  Naltrexone SR/Bupropion SR (Contrave): A New Approach to Weight Loss in Obese Adults.

Authors:  Tehane Ornellas; Benjamin Chavez
Journal:  P T       Date:  2011-05

8.  Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: intervention and 24 month follow-up effects.

Authors:  Bryan Blissmer; Deborah Riebe; Gabriela Dye; Laurie Ruggiero; Geoffrey Greene; Marjorie Caldwell
Journal:  Health Qual Life Outcomes       Date:  2006-07-17       Impact factor: 3.186

9.  A randomized, open-label pilot of the combination of low-level laser therapy and lorcaserin for weight loss.

Authors:  Ivana T Croghan; Jon O Ebbert; Darrell R Schroeder; Ryan T Hurt; Victoria Hagstrom; Matthew M Clark
Journal:  BMC Obes       Date:  2016-09-29

Review 10.  An Overview of Factors Associated with Adherence to Lifestyle Modification Programs for Weight Management in Adults.

Authors:  Alice W Y Leung; Ruth S M Chan; Mandy M M Sea; Jean Woo
Journal:  Int J Environ Res Public Health       Date:  2017-08-16       Impact factor: 3.390

View more
  3 in total

1.  Impact of Combined Photo-Biomodulation and Aerobic Exercise on Cognitive Function and Quality-of-Life in Elderly Alzheimer Patients with Anemia: A Randomized Clinical Trial.

Authors:  Ebtesam N Nagy; Ahmed Y Ali; Mervat E Behiry; Mervat M Naguib; Marwa M Elsayed
Journal:  Int J Gen Med       Date:  2021-01-14

2.  Evaluation of lipolysis and toxicological parameters of low-level laser therapy at different wavelengths and doses in the abdominal subcutaneous tissue.

Authors:  Marcia Gerhardt Martins; Maria Isabel Morgan Martins; Alessandra Hubner de Souza; Flavia Tasmin Techera Antunes; Priscilla Batista Pail; Elenir de Fátima Wiilland; Jaqueline Nascimento Picada; Lucimar Filot da Silva Brum
Journal:  Lasers Med Sci       Date:  2021-07-23       Impact factor: 3.161

3.  Study protocol for the use of photobiomodulation with red or infrared LED on waist circumference reduction: a randomised, double-blind clinical trial.

Authors:  Marcelo Marreira; Lidiane Rocha Mota; Daniela Fátima Teixeira Silva; Christiane Pavani
Journal:  BMJ Open       Date:  2020-08-11       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.